screening library
A screening library is the deck of cards you draw from when looking for hits: a curated collection of chemical compounds, stored ready-to-test, that gets screened against drug targets. Just as a good deck has variety, the value of a library depends not only on how many compounds it holds but on how diverse, high-quality, and drug-like they are.
Libraries vary enormously in design and purpose. General-purpose 'diversity' libraries spread compounds across chemical space to maximize the chance of hitting any target; focused libraries concentrate on chemotypes biased toward a target class such as kinases or GPCRs; fragment libraries hold small, simple molecules for fragment-based work. Curation matters as much as size: compounds are checked for purity, solubility, stability, and freedom from known interference (PAINS) substructures, and are kept in solution with quality control over time.
A bigger library is not automatically better. Adding unstable, insoluble, or PAINS-laden compounds inflates the count while raising the false-positive rate and the cost of follow-up. The best libraries are thoughtfully assembled for the target class and screening method at hand, balancing chemical diversity against the practical quality that makes downstream hits trustworthy.
A company maintains a 1.2-million-compound diversity collection plus a 30,000-compound kinase-focused set, choosing which to run based on the target class.
Libraries are matched to the target class — broad diversity for novelty, focused sets for known chemotypes.
Library quality, not headcount, drives screening success. A million junk compounds yield mostly junk hits; a well-curated, diverse, drug-like collection yields fewer but more tractable starting points.